FDA’s “Belt and Suspenders” Approach to Mifepristone Approval
Political pressure and wary regulators shaped FDA’s mifepristone approval in 2000.
Seeking Continuous Improvement to the Administrative Process
ACUS identifies best practices for agency guidance, adjudications, and responses to constituent service requests.
Week in Review
The Supreme Court agreed to hear a constitutional challenge concerning health insurance, President Biden issues an order establishing an AI infrastructure framework, and more…
Applying Antitrust to Discriminatory State Monopolies
Scholars argue that antitrust law can be used to scrutinize state monopoly power and advance equality.
When Money Talks, Agencies Listen
Scholars discuss how wealthy interest groups influence agency rulemaking.
Defining Discrimination in Health Care
The future of gender-affirming care may turn on the definition of “sex discrimination” in the Affordable Care Act.
Harnessing Clean Energy for Grid Reliability
Shelley Welton discusses how a comprehensive regulatory strategy for electric grid reliability can facilitate a transition to clean energy.
Week in Review
President Biden restricts oil and gas leasing on U.S. coastlines, the Justice Department brings antitrust case against major landlords, and more…
Revisiting EPA’s Forever Chemical Strategy
EPA has made significant progress on PFAS regulation over the past three years, but more work remains.